Stock Jumps 9% After Securing Approval to Migrate from NSE EMERGE to NSE Mainboard

SYNOPSIS: The company has received final approval to migrate from the NSE EMERGE platform to the NSE mainboard, with its equity shares set to commence trading in the Capital Market segment from March 12, 2026.

During Wednesday’s trading session, shares of India’s only publicly listed company exclusively focused on the production of biodiesel and related by-products, surged nearly 9 percent on NSE, after the company secured final approval for NSE mainboard migration.

With a market cap of Rs. 334 crores, shares of Kotyark Industries Limited are currently trading in the green at Rs. 325 on NSE, up by around 5 percent, compared to its previous closing price of Rs. 310.7. The stock has delivered negative returns of around 32 percent in one year, but has gained by over 52 percent in the last one month.

What’s the News

As per the latest disclosures with the NSE, Kotyark Industries Limited has received final approval for the listing and trading of its equity shares on the mainboard of the National Stock Exchange, marking its migration from the NSE EMERGE platform, which is designed for small and medium enterprises.

Following this approval, the company highlighted that the Equity Shares of the company shall be admitted for trading on the National Stock Exchange (Capital Market Segment – Main Board) with effect from 12th March 2026.

Financials & More

Kotyark Industries reported a decline in its revenue from operations, showing a year-on-year decrease of over 25 percent from Rs. 197 crores in H1 FY25 to Rs. 147 crores in H1 FY26. Likewise, its net profit decreased from Rs. 18 crores to Rs. 7 crores, representing a fall of nearly 61 percent YoY.

Kotyark Industries Limited is at the forefront of transforming the biofuels industry by offering sustainable alternatives to conventional fossil fuels. It holds the distinction of being India’s only publicly listed company exclusively focused on the production of biodiesel and related by-products.

The company operates 2 strategically located manufacturing facilities in Sirohi (Rajasthan) and Anand (Gujarat), with a combined annual production capacity of around 4,80,000 KL of biodiesel and about 63,000 KL of glycerine.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Stock Jumps 9% After Securing Approval to Migrate from NSE EMERGE to NSE Mainboard appeared first on Trade Brains.